SMTL ID : 8bxr.1

Titin FnIII-domain I109-I111 (I/A4-A/A6) from the MIR region

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 4 residues within 4Å: Chain A: V.153, T.154, D.155, F.158 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.154, A:T.154, A:D.155 EDO.2: 1 residues within 4Å: Chain A: N.22 No protein-ligand interaction detected (PLIP) EDO.3: 4 residues within 4Å: Chain A: F.42, K.74, G.75, I.76 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.76 EDO.4: 4 residues within 4Å: Chain A: K.148, D.151, F.152, R.176 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.148, A:R.176 EDO.5: 6 residues within 4Å: Chain A: F.42, L.47, R.52, V.53, D.73, Y.77 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.77, A:Y.77 EDO.6: 4 residues within 4Å: Chain A: D.226, G.228, S.229, R.230 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.228

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stergiou, C. et al., Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines (2023)

Release Date

2023-02-15

Peptides

Titin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Titin